SCHEMBL3501101

SCHEMBL3501101

O=C(O)c1cc2cc(-c3ccc(Cl)cc3)ccc2[nH]c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.56
ALDH1A1 P00352 1/20 0.56
POLB P06746 1/20 0.56
GAA P10253 1/20 0.56
GRIK1 P39086 2/20 0.54
GRIK2 Q13002 2/20 0.54
GRIK3 Q13003 2/20 0.54
GRIA1 P42261 1/20 0.54
GRIA2 P42262 1/20 0.54
GRIA3 P42263 1/20 0.54
GRIA4 P48058 1/20 0.54
F7 P08709 2/20 0.49
F3 P13726 2/20 0.49
DAO P14920 1/20 0.49
FFAR1 O14842 1/20 0.44
CHEK2 O96017 1/20 0.43
NHERF1 O14745 1/20 0.42
DHODH Q02127 1/20 0.42
NOTUM Q6P988 1/20 0.42
DYRK1A Q13627 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29696883 0.88 KDM4E (0.58) KDM4EALDH1A1POLBGAAGRIK1
SCHEMBL2310250 0.88 F7 (0.63) KDM4EALDH1A1POLBGAAGRIK1
SCHEMBL3500217 0.83 KDM4E (0.48) KDM4EALDH1A1POLBGAADAO
SCHEMBL3499567 0.80 F7 (0.76) KDM4EALDH1A1F7F3DAO
SCHEMBL9249785 0.78 DAO (0.63) KDM4EALDH1A1POLBGAAF7
SCHEMBL31422913 0.78 DAO (0.63) KDM4EALDH1A1POLBGAAF7
SCHEMBL29415468 0.76 KDM4E (0.63) KDM4EALDH1A1POLBGAAGRIK1
SCHEMBL2806050 0.76 KDM4E (0.63) KDM4EALDH1A1POLBGAAGRIK1
SCHEMBL1367967 0.76 DAO (0.65) KDM4EALDH1A1POLBGAAF7
Hydrochloric Acid SCHEMBL7273927 0.76 MMP2 (0.54) KDM4EALDH1A1POLBGAADHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-05-27 US disclosed
EP-1849465-A1 AGENT FOR CONTROLLING FUNCTION OF GPR34 RECEPTOR Takeda Pharmaceutical Company Limited (JP) 2007-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130737-A1 Regulating Agent of GPR34 Receptor Function GPR34, GPR4, GPR6 KDM4E 2059/4885ALDH1A1 3047/4885POLB 4658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.